Lilly Strikes $3.8 Billion Deal for Psychedelic Drugmaker
Membership required
Membership is now required to use this feature. To learn more:
View Membership BenefitsEmail Article Recommendation
Sponsored Content
Upcoming Virtual Events View All
July 20, 2026 at
12:30 PM EDT
The Outsized Impact of Microreactor Progress on the Nuclear Industry
July 20, 2026 at
01:30 PM EDT
Uncapped Nasdaq 100 (NDX) upside potential with a targeted limit on losses
July 21, 2026 at
12:30 PM EDT
T. Rowe Price Capital Appreciation income and dynamic allocation strategies
July 23, 2026 at
11:00 AM EDT
- 1.0 CE credit
Rethinking Active and Passive Investing with Data-Enhanced ETFs
July 27, 2026 at
12:30 PM EDT
Powering the Future: The Investment Case for Electrification Infrastructure
July 28, 2026 at
11:30 AM EDT
- 1.0 CE credit
Navigating What’s Next: Market Outlook and Portfolio Positioning for the Rest of the Year
July 29, 2026 at
12:30 PM EDT
Core portfolio strength may matter more than ever
July 30, 2026 at
02:00 PM EDT
- 1.0 CE credit
Inside the Fastest-Growing Corner of the Income ETF Market
July 31, 2026 at
02:00 AM EDT
- 1.0 CE credit
Hard Assets, Low Obsolescence: A Framework for Investing in the Age of AI
August 04, 2026 at
02:00 PM EDT
- 1.0 CE credit
The Evolution of Income Investing: What Advisors Need to Know
August 10, 2026 at
12:30 PM EDT
From Insight to Alpha: Seek Client Results with Collective Conviction
August 11, 2026 at
04:00 PM EDT
- 1.0 CE credit
Automating America: The New Wave of Robotics Demand
August 26, 2026 at
02:00 PM EDT
- 1.0 CE credit
The secular case for emerging markets growth
August 31, 2026 at
12:30 PM EDT
The importance of hedging foreign currency exposure in your equity portfolio
November 12, 2026 at
11:00 AM EST
- 1.0 CE credit
2027 Market Outlook Symposium
